HitGen, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000040G3
CNY
29.84
12.58 (72.89%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About HitGen, Inc. stock-summary
stock-summary
HitGen, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
142 Million
(Quarterly Results - Sep 2025)
Net Profit:
42 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 9,604 Million (Large Cap)

stock-summary
P/E

80.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.25%

stock-summary
Debt Equity

-0.54

stock-summary
Return on Equity

9.46%

stock-summary
Price to Book

6.53